15-Jan-10 10:00 AM CST
Tylenol Recall Expanded to More OTC Products
McNeil Consumer Healthcare Products expanded its recall of Tylenol products to include Motrin, Rolaids, Benadryl and more over-the-counter products today.
In December, McNeil had recalled certain lots of Tylenol Arthritis due to a moldy smell that made some consumers sick. McNeil, a subsidiary of Johnson & Johnson, has again expanded the recall to include more Tylenol products like geltabs, rapid release, and extended relief pills as well as Motrin IB, regular and extra strength Rolaids antacids, and Benadryl allergy tablets.
The odor’s source comes from a chemical called 2,4,6-tribromoanisole that can manifest itself in wood pallets that transport packaging materials. Somehow, the chemical found its way into certain packages of Tylenol Arthritis, causing the smell. As a precaution, McNeil is expanding the recall to other product lots that may have been contaminated by the chemical.
The company still has no idea how the chemical came into contact with the packaging materials. In addition to investigating the issue, McNeil has stopped shipping their products on the wood pallets in question and has issued an order requiring suppliers to discontinue the use of wood pallets.
A full list of products included in the recall is available on McNeil's Product Recall Information site. For instructions on how to return products listed in the recall or dispose of them, call 1-888-222-6036. Consumers who have medical questions or feel they may have been affected by any of the recalled products should consult with their doctor or contact the FDA MedWatch Program.
Rating: 0.00 / 5.00
-
0 ratings
Comments:
•
del.icio.us
digg
facebook
E-mail this article to a friend (requires login).
For additional information on this Article article, please contact:
Kristina Michel
(888) 247-8700
Related Documents:
Content Tags: article •
Tags: Benadryl cpht Johnson Johnson McNeil Motrin npta pharmacy pharmacy technician Recall Rolaids Tylenol
Other Recent Articles:
- Intensive Corticosteroid Treatment May be Best in Treating Severe Lupus 28-Jul-10
- FDA Suspends Enrollment in Avandia Clinical Trial 27-Jul-10
- New Painless Flu Patch Could Change How People Receive Vaccines 21-Jul-10
- FDA Warns of Stolen Advair 20-Jul-10
- FDA Advisory Panel Reviews Avandia 15-Jul-10
- Scientists Discover Potent HIV Antibodies That Could Boost Vaccine Research 14-Jul-10
- Study Ties Gene in Fat Cells to Type 2 Diabetes 9-Jul-10
- International Study to Examine Benefits of Aspirin in the Elderly 8-Jul-10
- First Ever Generic Version of Effexor XR FDA-Approved 30-Jun-10
- P&G Recalls Nasal Spray 30-Jun-10
Return to Pharmacy Technician Articles Search
